Volume | 17,442 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 2.88 | Mínimo Máximo |
|||||
Minimo del Dia | 2.74 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
MyMD Pharmaceuticals Inc | MYMD | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
2.85 | 2.74 | 2.88 | 2.84 | 2.81 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
207 | 17,442 | US$ 2.81 | US$ 49,062 | - | 2.00 - 70.50 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
18:54:03 | 1 | US$ 2.88 | USD |
Información Financiera MyMD Pharmaceuticals Inc MYMD
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
5.94M | 2.09M | - | 0 | -8.22M | -3.93 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre MyMD Pharmaceuticals Inc MYMD
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
07/3/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
05/3/2024 | 10:00 | Edgar (US Regulatory) | Form 8-K - Current report |
05/3/2024 | 08:15 | Business Wire | MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum.. |
14/2/2024 | 14:13 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
14/2/2024 | 10:27 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
13/2/2024 | 15:57 | Edgar (US Regulatory) | Form 8-K - Current report |
13/2/2024 | 10:45 | Business Wire | MyMD Pharmaceuticals Announces Reverse Stock Split to.. |
06/12/2023 | 08:15 | Edgar (US Regulatory) | Form 8-K - Current report |
06/12/2023 | 08:15 | Business Wire | MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical.. |
19/10/2023 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
19/10/2023 | 08:00 | Business Wire | MyMD Announces Preclinical Study Results Showing Novel.. |
13/10/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos MYMD
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.50 | 2.9324 | 2.50 | 2.72 | 46,174 | 0.34 | 13.60% |
1 Month | 2.40 | 3.50 | 2.00 | 2.61 | 651,045 | 0.44 | 18.33% |
3 Months | 4.35 | 4.50 | 2.00 | 3.27 | 428,547 | -1.51 | -34.71% |
6 Months | 12.687 | 12.903 | 2.00 | 6.66 | 977,275 | -9.85 | -77.61% |
1 Year | 57.00 | 70.50 | 2.00 | 18.39 | 818,392 | -54.16 | -95.02% |
3 Years | 123.60 | 298.50 | 2.00 | 53.07 | 419,780 | -120.76 | -97.70% |
5 Years | 162.90 | 298.50 | 2.00 | 57.62 | 438,322 | -160.06 | -98.26% |